Deutsche Bank cuts Xenon Pharmaceuticals to Hold from Buy
Deutsche Bank cut Xenon Pharmaceuticals from Buy to Hold and reduced its price target to $46.00 from $90.00, per Benzinga.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.